Clinical Trial: House Dust Mite Observational Study

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis

Brief Summary: A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis

Detailed Summary:

House Dust Mites (HDM) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDMA in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients.

The proposed observational study is designed to gather information on subjects with HDM-related rhinoconjunctivitis.

Sponsor: Circassia Limited

Current Primary Outcome: To Document the combined Total Rhinocnjunctivitis Systom Scores (TRSS) and Total allergy medication score [ Time Frame: 5 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Circassia Limited

Dates:
Date Received: September 20, 2013
Date Started: September 2013
Date Completion:
Last Updated: May 14, 2014
Last Verified: May 2014